Clinical Trial Update: High-dose Cytarabine and Survival in AML

View source ↗

Summary

This is a completed clinical trial update assessing whether high-dose cytarabine affects survival in patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Acute Myeloid Leukemia | Status: COMPLETED